A newly developed therapy inspired by bacteria residing within tumors offers a different way to combat cancer by targeting ...

High dose and low dose AMT-130 demonstrated an 80% and 30% slowing of disease progression vs external control, respectively. The Food and Drug Administration has granted Breakthrough Therapy ...

Nipocalimab 15mg/kg improved ClinESSDAI score compared with placebo (treatment difference -2.65; [90% CI, -4.03, -1.28]; P =.002). The Food and Drug Administration (FDA) has granted Breakthrough ...

Pediatric patients with Intestinal Failure (IF) due to MVID, an ultrarare congenital disorder with lethal natural ...

Breakthrough Therapy designation granted based on FDA’s review of available clinical evidence of safety and efficacy from all 12 patients treated in Part A of the REVEAL Phase 1/2 trials Finalized FDA ...

Prolong Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, announced today that its investigational therapy, ...

A revelatory treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne by researchers at The Alfred and Monash University.

Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions, announced that Eitan Insights™ has been selected as winner of the "Best Overall Connected Healthcare Solution" ...

At Breakthrough Therapy and Resources, we provide clinical support for individuals experiencing distress due to various life experiences. Utilizing a range of therapeutic interventions, we offer ...